Pain response Signs and Symptoms Pain
Conditions
Interventions
After obtained informed consent from the mother and the alternative female, the neonate will be randomised to:
1. Control group: mother first and alternative female second, or
one with the mother and one with the alternative female. The measures will be taken for the entire heel-lance procedure (one minute baseline, one minute warming of the neonate's foot, stick, extractio
Sponsors
Montreal Inter-University Group for Nursing Research (GRISIM) (Canada)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Born between 28 0/7 weeks and 36 6/7 gestational age 2. Obtained consent 3. Receiving at least two heel lances prior to discharge 4. Within 10 days of hospitalisation 5. Neonate has to be stable according to the Neonatal Intensive Care Unit criteria 6. Alternate female had to be healthy and older than 18 years old
Exclusion criteria
Exclusion criteria: Does not comply with the inclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Pain measured with Premature Infant Pain Profile (PIPP) 2. Facial actions of the PIPP scored according to Neonatal Facial Coding System (NFCS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Time for return to physiological baseline measured as the preterm neonate's return to baseline Heart Rate (HR) after the heel lance procedure procured via an oximeter placed on the unaffected foot of the neonate. | — |
Countries
Canada
Outcome results
None listed